Bristol-Myers Squibb Co (NYSE:BMY)
| 66.79 Delayed Data As of Jun 17 |  +0.02 / +0.03%Today’s Change | 54.73 Today|||52-Week Range 67.96 | +7.67% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 66.77 |
| Today’s open | 66.99 |
| Day’s range | 66.24 - 67.17 |
| Volume | 1,275 |
| Average volume (3 months) | 11,270,036 |
| Market cap | $150.4B |
Data as of 4:00pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +15.87% |
| Earnings growth (next 5 years) | +5.97% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 4.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.06 | -0.10% |
| NVONovo Nordisk | -0.86 | -1.03% |
| SNYSanofi | -0.18 | -0.34% |
| LLYEli Lilly and Co | +0.12 | +0.05% |
Data as of 4:27pm ET, 06/17/2021
Financials
| Next reporting date | July 28, 2021 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
